Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 4Stomach Neoplasms 2Adenocarcinoma 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Diseases 1Neoplasms by Site 1Neoplasms 1Nasopharyngeal Carcinoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced Biliary Tract Carcinoma 1

Interventions

gadolinium ethoxybenzyl DTPA 1gadobutrol 1encorafenib 1durvalumab 1camrelizumab 1Urine Specimen Collection 1Tomography, X-Ray Computed 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Oxaliplatin 1Levoleucovorin 1Leucovorin 1Irinotecan 1Immunotherapy 1Hydromorphone 1Fluorouracil 1Fentanyl 1Cetuximab 1Capecitabine 1Bupivacaine 1Blood Specimen Collection 1Biopsy 1Bevacizumab 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Digestive System Diseases × camrelizumab × Clear all
NCT05602935 2023-09-28

Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study

The Second Affiliated Hospital of Fujian Medical University

Phase 2 Active not recruiting
29 enrolled
Gastrointestinal

Digestive System Diseases, Digestive System Neoplasms, Neoplasms, Neoplasms by Site, Stomach Diseases, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡